Get the latest Science News and Discoveries

Repurposed drug may help stabilize vision in rare disease - EurekAlert


Ophthalmologist Rajendra S. Apte, MD, PhD, (right), of Washington University School of Medicine in St. Louis, examines patient Patricia Collins (left) while medical student Wilson Wang observes. Collins is a participant in a clinical trial that tests the safety and efficacy of an FDA-approved drug in stabilizing vision in patients with RVCL-S, a rare genetic disease that affects tiny blood vessels in the body. 

None

Get the Android app

Or read this on Eureka Alert

Read more on:

Photo of Rare disease

Rare disease

Photo of vision

vision

Photo of Repurposed drug

Repurposed drug

Related news:

News photo

Breakthrough approach enables bidirectional BCI functionality - EurekAlert

News photo

A new way to measure ageing and disease risk with the protein aggregation clock - EurekAlert

News photo

Making this Parkinson's drug is just turtles all the way down (video) - EurekAlert